Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...
Oil prices are climbing again as geopolitical risks and supply constraints threaten the global market. Analysts warn ...
Ranger Investment Management recently boosted its WaterBridge stake, signaling potential confidence in WaterBridge In...
Two defendants, Real Brokerage and The Frano Team, were voluntarily dismissed without prejudice from the Taylor RESPA...
AutoZone beat on revenue but missed top-line estimates, while margins narrowed and shares fell. The focus: margins cr...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...
Beldex expands beyond a single coin, rolling out a privacy-first ecosystem that spans private transactions, messaging...
Accenture says it will hire more entry-level graduates this year than last, citing a need to onboard Gen Z workers wh...
The Federal Reserve’s annual stress tests show 32 large banks surviving a severe unemployment shock, with capital cus...